MentionFox
Home › Stakes › Arcturus Therapeutics Holdings Inc.
5%+ stakes · Schedule 13D and 13G

Arcturus Therapeutics Holdings Inc.: 5%+ holders

Who has reported owning 5% or more of Arcturus Therapeutics Holdings Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more4
Filings10
Latest filing2026-05-07

Arcturus Therapeutics Holdings Inc. has 10 Schedule 13D or 13G filings on record since 2025-07-29. 4 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Federated Hermes, Inc.11.63%3,303,640SCHEDULE 13G/A, 2026-01-082025-12-31
ARK Investment Management LLC10.37%2,947,556SCHEDULE 13G/A, 2026-05-072026-04-30
Sumitomo Mitsui Trust Group, Inc.7.2%1,947,835SCHEDULE 13G/A, 2025-10-272025-09-30
Amova Asset Management Americas, Inc.7.2%1,947,835SCHEDULE 13G/A, 2025-11-132025-09-30
The Vanguard Group0%0SCHEDULE 13G/A, 2026-03-262026-03-13
Balyasny Asset Management L.P.0%0SCHEDULE 13G/A, 2026-02-172025-12-31

Timeline

FiledHolderPercentFiling
2025-07-29The Vanguard Group6.67%SCHEDULE 13G/A
2025-07-30ARK Investment Management LLC6.32%SCHEDULE 13G/A
2025-10-27Sumitomo Mitsui Trust Group, Inc.7.2%SCHEDULE 13G/A
2025-11-13Amova Asset Management Americas, Inc.7.2%SCHEDULE 13G/A
2025-11-14Balyasny Asset Management L.P.8.04%SCHEDULE 13G
2026-01-08Federated Hermes, Inc.11.63%SCHEDULE 13G/A
2026-02-03ARK Investment Management LLC9.19%SCHEDULE 13G/A
2026-02-17Balyasny Asset Management L.P.0%SCHEDULE 13G/A
2026-03-26The Vanguard Group0%SCHEDULE 13G/A
2026-05-07ARK Investment Management LLC10.37%SCHEDULE 13G/A

Tools for this story

Each opens in a new tab, filled in for Arcturus Therapeutics Holdings Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/arcturus-therapeutics-holdings
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Arcturus Therapeutics Holdings Inc. 5%+ holders: 4 at 5% or more, largest Federated Hermes, Inc. 11.63%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/arcturus-therapeutics-holdings